- Report
- April 2024
- 175 Pages
Global
From €4804EUR$5,000USD£4,107GBP
- Report
- January 2023
- 167 Pages
Global
From €3459EUR$3,600USD£2,957GBP
- Report
- April 2023
- 156 Pages
Global
€4804EUR$5,000USD£4,107GBP
- Report
- April 2023
- 114 Pages
Global
€3363EUR$3,500USD£2,875GBP
- Report
- March 2023
- 147 Pages
Global
From €5764EUR$5,999USD£4,928GBP
ProAir is a brand of respiratory drugs used to treat and prevent airway spasms in people with asthma, chronic obstructive pulmonary disease (COPD), and other breathing disorders. ProAir is a type of short-acting beta-agonist (SABA) bronchodilator, which works by relaxing the muscles in the airways to improve breathing. It is available in both inhaler and nebulizer forms, and is typically used to provide quick relief from symptoms such as wheezing, chest tightness, and shortness of breath.
ProAir is one of many respiratory drugs on the market, and is often used in combination with other medications to treat and prevent airway spasms. Other types of respiratory drugs include long-acting beta-agonists (LABAs), inhaled corticosteroids (ICS), and leukotriene modifiers.
Some companies that produce ProAir and other respiratory drugs include GlaxoSmithKline, Merck, Novartis, Pfizer, and Teva Pharmaceuticals. Show Less Read more